Texas Instruments shares slip after chip maker’s 1st-quarter update
Texas Instruments shares slip after 1Q update
NEW YORK — Shares of Texas Instruments Inc. slipped Tuesday as investors gave the chip maker’s latest financial projections a cool reception.
After the close Monday, Dallas-based TI raised the low end of its first-quarter earnings and sales estimates. But shares fell 68 cents, or 2.8 percent, to $24.01 in … Read more >>>.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research
